Sunzen Biotech Bhd (XKLS:0148) COGS-to-Revenue

: 0.00 (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

Sunzen Biotech Bhd's Cost of Goods Sold for the three months ended in Sep. 2023 was RM0.00 Mil. Its Revenue for the three months ended in Sep. 2023 was RM25.98 Mil.

Sunzen Biotech Bhd's COGS to Revenue for the three months ended in Sep. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sunzen Biotech Bhd's Gross Margin % for the three months ended in Sep. 2023 was N/A%.

Sunzen Biotech Bhd COGS-to-Revenue Historical Data

The historical data trend for Sunzen Biotech Bhd's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunzen Biotech Bhd Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

0.96

0.95

0.90

0.82

0.75

Sunzen Biotech Bhd Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
COGS-to-Revenue																-	-	-	-	-

Sunzen Biotech Bhd COGS-to-Revenue Calculation

Sunzen Biotech Bhd's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	73.168	/	97.094
	=	0.75

Sunzen Biotech Bhd's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	25.982
	=	0.00

Sunzen Biotech Bhd (XKLS:0148) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sunzen Biotech Bhd's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 25.982
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sunzen Biotech Bhd COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sunzen Biotech Bhd's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunzen Biotech Bhd (XKLS:0148) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sunzen Biotech Bhd (XKLS:0148) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, Jalan Anggerik Mokara 31/47, Kota Kemuning, Shah Alam, SGR, MYS, 40460

Website

https://www.sunzen.com.my

Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment.

Sunzen Biotech Bhd (XKLS:0148) Headlines

No Headlines